Dalton Pharma Services enters into a drug development and manufacturing services agreement with ExCellThera Inc.

Posted on November 22nd, 2018

This agreement provides ExCellThera access to Dalton’s State-of-the-Art cGMP, Health Canada approved biopharmaceutical facility in Toronto, ON, Canada. Under the agreement terms… PRWeb